HCP Plastene Bulkpack Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 7:37 pm

Quick Insight

HCP Plastene Bulkpack Ltd, a player in the Packaging & Containers sector, currently trades at ₹209 with a market capitalization of ₹224 Cr. The company's P/E ratio stands at 23.2, indicating investors are willing to pay 23.2 times the earnings for the stock. With a respectable ROE of 17.7% and ROCE of 13.2%, HCP Plastene Bulkpack Ltd shows efficient utilization of capital. However, the OPM at 11% suggests room for improvement in operational efficiency. The company's low borrowings of ₹190 Cr and healthy ICR of 2.73x indicate a strong financial position. With a high promoter holding of 75% and low FII ownership at 0.07%, there is stability in ownership structure. In conclusion, while the company exhibits solid financial health, focusing on enhancing operational margins could further drive shareholder value.

Competitors of HCP Plastene Bulkpack Ltd

All Competitor Stocks of HCP Plastene Bulkpack Ltd

Quarterly Result

Last Updated: May 31, 2025, 5:44 am

Below is a detailed analysis of the quarterly data for HCP Plastene Bulkpack Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 122.00 Cr.. The value appears strong and on an upward trend. It has increased from 119.00 Cr. (Dec 2024) to 122.00 Cr., marking an increase of 3.00 Cr..
• For Expenses, as of Mar 2025, the value is 109.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 111.00 Cr. (Dec 2024) to 109.00 Cr., marking a decrease of 2.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Dec 2024) to 13.00 Cr., marking an increase of 5.00 Cr..
• For OPM %, as of Mar 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Dec 2024) to 11.00%, marking an increase of 4.00%.
• For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Dec 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 4.00 Cr..
• For Depreciation, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Dec 2024) to 9.00 Cr., marking an increase of 6.00 Cr..
• For Tax %, as of Mar 2025, the value is -16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Dec 2024) to -16.00%, marking a decrease of 45.00%.
• For Net Profit, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Dec 2024) to 11.00 Cr., marking an increase of 9.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 4.72. The value appears strong and on an upward trend. It has increased from 1.41 (Dec 2024) to 4.72, marking an increase of 3.31.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 19, 2025, 11:54 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:07 pm

Below is a detailed analysis of the balance sheet data for HCP Plastene Bulkpack Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2024) to 49.00 Cr., marking an increase of 10.00 Cr..
• For Borrowings, as of Mar 2025, the value is 190.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 158.00 Cr. (Mar 2024) to 190.00 Cr., marking an increase of 32.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 233.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 43.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 73.00 Cr.. The value appears to be declining and may need further review. It has decreased from 77.00 Cr. (Mar 2024) to 73.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 203.00 Cr.. The value appears strong and on an upward trend. It has increased from 152.00 Cr. (Mar 2024) to 203.00 Cr., marking an increase of 51.00 Cr..
• For Total Assets, as of Mar 2025, the value is 276.00 Cr.. The value appears strong and on an upward trend. It has increased from 233.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 43.00 Cr..

However, the Borrowings (190.00 Cr.) are higher than the Reserves (49.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for HCP Plastene Bulkpack Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 12.51. This value is within the healthy range. It has increased from 0.37 (Mar 24) to 12.51, marking an increase of 12.14.
• For Diluted EPS (Rs.), as of Mar 25, the value is 9.02. This value is within the healthy range. It has increased from 0.37 (Mar 24) to 9.02, marking an increase of 8.65.
• For Cash EPS (Rs.), as of Mar 25, the value is 19.34. This value is within the healthy range. It has increased from 7.12 (Mar 24) to 19.34, marking an increase of 12.22.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.81. It has decreased from 61.23 (Mar 24) to 55.81, marking a decrease of 5.42.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.81. It has decreased from 61.23 (Mar 24) to 55.81, marking a decrease of 5.42.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 434.14. It has increased from 275.94 (Mar 24) to 434.14, marking an increase of 158.20.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 37.39. This value is within the healthy range. It has increased from 18.01 (Mar 24) to 37.39, marking an increase of 19.38.
• For PBIT / Share (Rs.), as of Mar 25, the value is 30.56. This value is within the healthy range. It has increased from 11.18 (Mar 24) to 30.56, marking an increase of 19.38.
• For PBT / Share (Rs.), as of Mar 25, the value is 16.86. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 16.86, marking an increase of 16.68.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 12.51. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 12.51, marking an increase of 12.23.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.02. This value is within the healthy range. It has increased from -1.11 (Mar 24) to 9.02, marking an increase of 10.13.
• For PBDIT Margin (%), as of Mar 25, the value is 8.61. This value is below the healthy minimum of 10. It has increased from 6.52 (Mar 24) to 8.61, marking an increase of 2.09.
• For PBIT Margin (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 10. It has increased from 4.04 (Mar 24) to 7.03, marking an increase of 2.99.
• For PBT Margin (%), as of Mar 25, the value is 3.88. This value is below the healthy minimum of 10. It has increased from 0.06 (Mar 24) to 3.88, marking an increase of 3.82.
• For Net Profit Margin (%), as of Mar 25, the value is 2.88. This value is below the healthy minimum of 5. It has increased from 0.10 (Mar 24) to 2.88, marking an increase of 2.78.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 8. It has increased from -0.40 (Mar 24) to 2.07, marking an increase of 2.47.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.15. This value is within the healthy range. It has increased from -2.39 (Mar 24) to 16.15, marking an increase of 18.54.
• For Return on Capital Employeed (%), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from 10.45 (Mar 24) to 28.33, marking an increase of 17.88.
• For Return On Assets (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 5. It has increased from -0.50 (Mar 24) to 3.48, marking an increase of 3.98.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.54, marking a decrease of 0.42.
• For Total Debt / Equity (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 1. There is no change compared to the previous period (Mar 24) which recorded 3.19.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.82. It has increased from 1.36 (Mar 24) to 1.82, marking an increase of 0.46.
• For Current Ratio (X), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 1.5. It has increased from 0.97 (Mar 24) to 1.06, marking an increase of 0.09.
• For Quick Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.71, marking an increase of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.62. This value is within the healthy range. It has increased from 6.74 (Mar 24) to 7.62, marking an increase of 0.88.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 3. It has increased from 1.64 (Mar 24) to 2.73, marking an increase of 1.09.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 3. It has increased from 1.03 (Mar 24) to 1.91, marking an increase of 0.88.
• For Enterprise Value (Cr.), as of Mar 25, the value is 319.31. It has decreased from 372.53 (Mar 24) to 319.31, marking a decrease of 53.22.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has decreased from 1.26 (Mar 24) to 0.68, marking a decrease of 0.58.
• For EV / EBITDA (X), as of Mar 25, the value is 8.00. This value is within the healthy range. It has decreased from 19.38 (Mar 24) to 8.00, marking a decrease of 11.38.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.23, marking a decrease of 0.44.
• For Price / BV (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has decreased from 4.03 (Mar 24) to 1.85, marking a decrease of 2.18.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.23, marking a decrease of 0.44.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.08, marking an increase of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness